Clinical Trials Directory

Trials / Terminated

TerminatedNCT00795236

Melatonin Studies of Totally Blind Children

Melatonin Studies in Young Blind Children and Adolescents

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
5 Years – 20 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn more about abnormal body rhythms in blind boys and girls that keep them from falling asleep at bed-time or cause them difficulty staying alert during the day. The investigators hope to learn if there are any differences between the body rhythms of girls and boys. The investigators also want to investigate whether age or puberty have an effect on body rhythms.

Detailed description

Subjects will be asked to collect saliva samples in their home hourly throughout the daytime, approximately every 2 weeks. Subjects may be monitored for up to a year, after which they will be discontinued from the study. If subjects are found to be naturally entrained to the 24-hour day, they will be monitored longitudinally for changes. Subjects will be discontinued after their monitoring period is over or after an entrained status has been confirmed. While no specific time commitment is required, we hope most subjects will participant for 4 months - 2 years.

Conditions

Interventions

TypeNameDescription
DRUGMelatoninOne 0.5 mg tablet of melatonin will be taken by subjects who are free-running and willing to enter the intervention phase of the study. These subjects will take melatonin until entrainment status is confirmed or throughout the duration of the study.

Timeline

Start date
2009-11-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2008-11-21
Last updated
2019-11-27
Results posted
2019-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00795236. Inclusion in this directory is not an endorsement.